Skip to content

Population pharmacokinetics of dexmedetomidine in ICU patients

Population pharmacokinetics of dexmedetomidine in ICU patients

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-002932-27-FI
Enrollment
30
Registered
2007-06-14
Start date
2007-08-29
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tutkimukseen otetaan 25 - 30 tehohoidossa olevaa potilasta, joille hoitavan lääkärin päätöksellä aloitetaan dexmedetomidiinisedaatio. MedDRA version: 9.1 Level: LLT Classification code 10022519 Term: Intensive care

Interventions

Trade Name: Precedex (Suomessa erityisluvalla) Product Name: Dexmedetomidiini / Precedex Pharmaceutical Form: Intravenous infusion

Sponsors

Turun yliopistollinen keskussairaala
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026